These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6190015)

  • 1. Transurethral prostatic resection in the treatment of prostatism with high urinary flow.
    Iversen P; Bruskewitz RC; Jensen KM; Madsen PO
    J Urol; 1983 May; 129(5):995-7. PubMed ID: 6190015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of low maximum flow rate in benign prostatic hyperplasia.
    Dorflinger T; Bruskewitz R; Jensen KM; Iversen P; Madsen PO
    Urology; 1986 Jun; 27(6):569-73. PubMed ID: 2424165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of transurethral resection of the prostate in men with moderate symptoms of prostatism.
    Lepor H; Rigaud G
    J Urol; 1990 Mar; 143(3):533-7. PubMed ID: 1689396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous uroflowmetry in prostatism.
    Jensen KM; Bruskewitz RC; Iversen P; Madsen PO
    Urology; 1984 Oct; 24(4):403-9. PubMed ID: 6207654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction.
    Zhao YR; Liu WZ; Guralnick M; Niu WJ; Wang Y; Sun G; Xu Y
    Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relevance of minimum urethral resistance in prostatism.
    Bruskewitz R; Jensen KM; Iversen P; Madsen PO
    J Urol; 1983 Apr; 129(4):769-71. PubMed ID: 6188866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of presenting symptoms in prostatism.
    Frimodt-Møller PC; Jensen KM; Iversen P; Madsen PO; Bruskewitz RC
    J Urol; 1984 Aug; 132(2):272-6. PubMed ID: 6204066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamics in prostatism. I. Prognostic value of uroflowmetry.
    Jensen KM; Jørgensen JB; Mogensen P
    Scand J Urol Nephrol; 1988; 22(2):109-17. PubMed ID: 2462745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of voiding dysfunction in patients awaiting transurethral prostatectomy.
    Javlé P; Jenkins SA; West C; Parsons KF
    J Urol; 1996 Sep; 156(3):1014-8; discussion 1018-9. PubMed ID: 8709299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.
    Küpeli S; Yilmaz E; Soygür T; Budak M
    J Endourol; 2001 Apr; 15(3):317-21. PubMed ID: 11339401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transurethral incision of the prostate: an objective and subjective evaluation of long-term efficacy.
    Sirls LT; Ganabathi K; Zimmern PE; Roskamp DA; Wolde-Tsadik G; Leach GE
    J Urol; 1993 Nov; 150(5 Pt 2):1615-21. PubMed ID: 7692097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visual laser ablation of the prostate (VLAP): an effective alternative treatment of benign prostatic hyperplasia.
    Mattelaer P; Jung P; Wolff J; Jakse G
    Acta Urol Belg; 1995 Sep; 63(3):45-9. PubMed ID: 7484522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
    Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
    J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urodynamic and histological correlates of benign prostatic hyperplasia.
    Dørflinger T; England DM; Madsen PO; Bruskewitz RC
    J Urol; 1988 Dec; 140(6):1487-90. PubMed ID: 2461453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic assessment of patients with acute urinary retention: is treatment failure after prostatectomy predictable?
    Djavan B; Madersbacher S; Klingler C; Marberger M
    J Urol; 1997 Nov; 158(5):1829-33. PubMed ID: 9334611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term results following transurethral resection of the prostate.
    Zwergel U; Wullich B; Lindenmeir U; Rohde V; Zwergel T
    Eur Urol; 1998; 33(5):476-80. PubMed ID: 9643667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of transurethral resection on the urodynamics of prostatism.
    Meyhoff HH; Gleason DM; Bottaccini MR
    J Urol; 1989 Sep; 142(3):785-9. PubMed ID: 2475646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic pressure flow studies can predict the clinical outcome after transurethral prostatic resection.
    Rodrigues P; Lucon AM; Freire GC; Arap S
    J Urol; 2001 Feb; 165(2):499-502. PubMed ID: 11176404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary incontinence after transurethral resection of prostate in myasthenia gravis patients.
    Khan Z; Bhola A
    Urology; 1989 Sep; 34(3):168-9. PubMed ID: 2476884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study of laser versus electrocautery prostatic resection: 18-month followup with complex urodynamic assessment.
    Kabalin JN; Gill HS; Bite G; Wolfe V
    J Urol; 1995 Jan; 153(1):94-7; discussion 97-8. PubMed ID: 7526006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.